Moleculin Biotech (MBRX) Tops Q1 EPS by 209c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.69), $2.09 better than the analyst estimate of ($2.78).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Methanex to idle Trinidad Titan plant after gas contract talks fail
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'